Novel therapies like poly (ADP-ribose) polymerase (PARP) inhibitors are one of such example where the induction of double stranded breaks in DNA leads to cell death in tumor cell with homologous DNA repair deficiency [26]. The gene discussed is PARP1; the disease is neoplasm.